Literature DB >> 20546304

Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry.

Jinn-Shiun Chen1, Kuei-Tien Chen, Chung-Wei Fan, Chia-Li Han, Yu-Ju Chen, Jau-Song Yu, Yu-Sun Chang, Chih-Wei Chien, Chien-Peng Wu, Ray-Ping Hung, Err-Cheng Chan.   

Abstract

The aim of this study was to uncover the membrane protein profile differences between colorectal carcinoma and neighboring normal mucosa from colorectal cancer patients. Information from cellular membrane proteomes can be used not only to study the roles of membrane proteins in fundamental biological processes, but also to discover novel targets for improving the management of colorectal cancer patients. We used solvent extraction and a gel-assisted digestion method, together with isobaric tags with related and absolute quantitation (iTRAQ) reagents to label tumoral and adjacent normal tissues in a pairwise manner (n = 8). For high-throughput quantification, these digested labeled peptides were combined and simultaneously analyzed using LC-MS/MS. Using the shotgun approach, we identified a total of 438 distinct proteins from membrane fractions of all eight patients. After comparing protein expression between cancerous and corresponding normal tissue, we identified 34 upregulated and eight downregulated proteins with expression changes greater than twofold (Student's t-test, P < 0.05). Among these, the overexpression of well-established biomarkers such as carcinoembryonic antigens (CEACAM5, CEACAM6), as well as claudin-3, HLA class I histocompatibility antigen A-1, tapasin and mitochondrial solute carrier family 25A4 were confirmed by western blotting. We conclude that gel-assisted digestion and iTRAQ labeling MS is a potential approach for uncovering and comparing membrane protein profiles of tissue samples that has the potential to identify novel biomarkers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546304     DOI: 10.1111/j.1742-4658.2010.07712.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  21 in total

1.  Identification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancer.

Authors:  Yung-Bin Kuo; Chung-Chuan Chan; C Allen Chang; Chung-Wei Fan; Ray-Ping Hung; Ya-Shu Hung; Kuei-Tien Chen; Jau-Song Yu; Yu-Sun Chang; Err-Cheng Chan
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

2.  Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.

Authors:  Hideaki Kume; Satoshi Muraoka; Takahisa Kuga; Jun Adachi; Ryohei Narumi; Shio Watanabe; Masayoshi Kuwano; Yoshio Kodera; Kazuyuki Matsushita; Junya Fukuoka; Takeshi Masuda; Yasushi Ishihama; Hisahiro Matsubara; Fumio Nomura; Takeshi Tomonaga
Journal:  Mol Cell Proteomics       Date:  2014-03-31       Impact factor: 5.911

3.  Identification of adipophilin as a potential diagnostic tumor marker for lung adenocarcinoma.

Authors:  Xue-De Zhang; Wei Li; Na Zhang; Yan-Li Hou; Ze-Qun Niu; Yu-Jie Zhong; Yu-Ping Zhang; Shuan-Ying Yang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

4.  Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Nazia Syed; Mustafa A Barbhuiya; Remya Raja; Arivusudar Marimuthu; Nandini Sahasrabuddhe; Sneha M Pinto; Srikanth Srinivas Manda; Santosh Renuse; H C Manju; Mohammed Abdul Lateef Zameer; Jyoti Sharma; Mariana Brait; Kotteazeth Srikumar; Juan Carlos Roa; M Vijaya Kumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha Vijay Kumar; Akhilesh Pandey; Harsha Gowda; Aditi Chatterjee
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.

Authors:  Ágnes Holczbauer; Benedek Gyöngyösi; Gábor Lotz; Attila Szijártó; Péter Kupcsulik; Zsuzsa Schaff; András Kiss
Journal:  J Histochem Cytochem       Date:  2013-02-05       Impact factor: 2.479

6.  Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry.

Authors:  Xuede Zhang; Wei Li; Yanli Hou; Zequn Niu; Yujie Zhong; Yuping Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

Review 7.  Proteomics for discovery of candidate colorectal cancer biomarkers.

Authors:  Paula Alvarez-Chaver; Olalla Otero-Estévez; María Páez de la Cadena; Francisco J Rodríguez-Berrocal; Vicenta S Martínez-Zorzano
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

8.  SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca(2+) buffering.

Authors:  J Traba; A Del Arco; M R Duchen; G Szabadkai; J Satrústegui
Journal:  Cell Death Differ       Date:  2011-10-21       Impact factor: 15.828

Review 9.  Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex.

Authors:  Mark Sicking; Sven Lang; Florian Bochen; Andreas Roos; Joost P H Drenth; Muhammad Zakaria; Richard Zimmermann; Maximilian Linxweiler
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

10.  Parkin protein expression and its impact on survival of patients with advanced colorectal cancer.

Authors:  Claudia Caroline Veloso da Silva-Camargo; Rosimeri Kuhl Svoboda Baldin; Nayanne Louise Costacurta Polli; Amanda Pereira Agostinho; Marcia Olandosk; Lúcia de Noronha; Vanessa Santos Sotomaior
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.